Table 6 Oversight committee split by intervention type
Intervention type | Committee(s) reported | ||||||||
|---|---|---|---|---|---|---|---|---|---|
TSC and DMC | TSC and no DMC | DMC and no TSC | No TSC and no DMC | ||||||
N | n | n/N% | n | n/N% | n | n/N% | n | n/N% | |
Pharmaceutical | 132 | 60 | 45.5% | 8 | 6.1% | 37 | 28.0% | 27 | 20.5% |
Cellular and gene therapy | 3 | 0 | 0.0% | 0 | 0.0% | 2 | 66.7% | 1 | 33.3% |
Medical device | 26 | 16 | 61.5% | 1 | 3.8% | 3 | 11.5% | 6 | 23.1% |
Surgery | 14 | 6 | 42.9% | 3 | 21.4% | 3 | 21.4% | 2 | 14.3% |
Radiotherapy | 13 | 4 | 30.8% | 3 | 23.1% | 1 | 7.7% | 5 | 38.5% |
Psychological and behavioural | 29 | 9 | 31.0% | 5 | 17.2% | 2 | 6.9% | 13 | 44.8% |
Physical | 14 | 7 | 50.0% | 4 | 28.6% | 1 | 7.1% | 2 | 14.3% |
Complimentary | 6 | 2 | 33.3% | 1 | 16.7% | 0 | 0.0% | 3 | 50.0% |
Resources and infrastructure | 22 | 4 | 18.2% | 9 | 40.9% | 1 | 4.5% | 8 | 36.4% |
Other | 19 | 7 | 36.8% | 6 | 31.6% | 0 | 0.0% | 6 | 31.6% |